The Swarm: Causes and consequences of HIV quasispecies diversity

Similar documents
A VACCINE FOR HIV BIOE 301 LECTURE 10 MITALI BANERJEE HAART

MedChem 401~ Retroviridae. Retroviridae

5. Over the last ten years, the proportion of HIV-infected persons who are women has: a. Increased b. Decreased c. Remained about the same 1

Immunodeficiency. (2 of 2)

Viral Genetics. BIT 220 Chapter 16

HIV Drug Resistance. Together, we can change the course of the HIV epidemic one woman at a time.

Fayth K. Yoshimura, Ph.D. September 7, of 7 HIV - BASIC PROPERTIES

HIV 101: Fundamentals of HIV Infection

cure research HIV & AIDS

3. on T helper {cells / lymphocytes} ; 3. ACCEPT macrophages / dendritic cells / CD4 cells

Antiviral Drugs Lecture 5

Evolution of influenza

HIV Immunopathogenesis. Modeling the Immune System May 2, 2007

Lecture 2: Virology. I. Background

HIV/AIDS. Biology of HIV. Research Feature. Related Links. See Also

How HIV Works in Your Body

HIV & AIDS: Overview

Citation for published version (APA): Von Eije, K. J. (2009). RNAi based gene therapy for HIV-1, from bench to bedside

Lecture 11. Immunology and disease: parasite antigenic diversity

CHAPTER - IV OBJECTIVES OF THE STUDY

numbe r Done by Corrected by Doctor

BIT 120. Copy of Cancer/HIV Lecture

LESSON 4.4 WORKBOOK. How viruses make us sick: Viral Replication

Viral reproductive cycle

A PROJECT ON HIV INTRODUCED BY. Abdul Wahab Ali Gabeen Mahmoud Kamal Singer

SECTION 25-1 REVIEW STRUCTURE. 1. The diameter of viruses ranges from about a. 1 to 2 nm. b. 20 to 250 nm. c. 1 to 2 µm. d. 20 to 250 µm.

How HIV Causes Disease Prof. Bruce D. Walker

7.013 Spring 2005 Problem Set 7

Fig. 1: Schematic diagram of basic structure of HIV

Models of HIV during antiretroviral treatment

Micropathology Ltd. University of Warwick Science Park, Venture Centre, Sir William Lyons Road, Coventry CV4 7EZ

MID-TERM EXAMINATION

Chapter 24 The Immune System

Structure of HIV. Virion contains a membrane envelope with a single viral protein= Env protein. Capsid made up of Gag protein

Immunity and Infection. Chapter 17

LESSON 4.6 WORKBOOK. Designing an antiviral drug The challenge of HIV

ARV Mode of Action. Mode of Action. Mode of Action NRTI. Immunopaedia.org.za

Medical Virology Immunology. Dr. Sameer Naji, MB, BCh, PhD (UK) Head of Basic Medical Sciences Dept. Faculty of Medicine The Hashemite University

Structure of viruses

Acquired Immune Deficiency Syndrome (AIDS)

Human Genome Complexity, Viruses & Genetic Variability

EVOLUTION. Reading. Research in my Lab. Who am I? The Unifying Concept in Biology. Professor Carol Lee. On your Notecards please write the following:

11/15/2011. Outline. Structural Features and Characteristics. The Good the Bad and the Ugly. Viral Genomes. Structural Features and Characteristics

PhysicsAndMathsTutor.com. Question Number. 1. prevents viruses attaching to {uninfected / eq} host cells / eq ; 2. by binding to receptors / eq ;

HIV replication and selection of resistance: basic principles

Prevention of infection 2 : immunisation. How infection influences the host : viruses. Peter

A new wild-type in the era of transmitted drug resistance

Human Immunodeficiency Virus

AP Biology. Viral diseases Polio. Chapter 18. Smallpox. Influenza: 1918 epidemic. Emerging viruses. A sense of size

KEY CONCEPT Germs cause many diseases in humans.

Ch 18 Infectious Diseases Affecting Cardiovascular and Lymphatic Systems

7.012 Quiz 3 Answers

Adaptive Immunity: Humoral Immune Responses

Some living things are made of ONE cell, and are called. Other organisms are composed of many cells, and are called. (SEE PAGE 6)

PAEDIATRIC HIV INFECTION. Dr Ashendri Pillay Paediatric Infectious Diseases Specialist

MID 36. Cell. HIV Life Cycle. HIV Diagnosis and Pathogenesis. HIV-1 Virion HIV Entry. Life Cycle of HIV HIV Entry. Scott M. Hammer, M.D.

LESSON 4.5 WORKBOOK. How do viruses adapt Antigenic shift and drift and the flu pandemic

HIV/AIDS & Immune Evasion Strategies. The Year First Encounter: Dr. Michael Gottleib. Micro 320: Infectious Disease & Defense

Treatment of respiratory virus infection Influenza A & B Respiratory Syncytial Virus (RSV)

19 Viruses BIOLOGY. Outline. Structural Features and Characteristics. The Good the Bad and the Ugly. Structural Features and Characteristics

DEBATE ON HIV ENVELOPE AS A T CELL IMMUNOGEN HAS BEEN GAG-GED

2 nd Line Treatment and Resistance. Dr Rohit Talwani & Dr Dave Riedel 12 th June 2012

RAISON D ETRE OF THE IMMUNE SYSTEM:

Immunodeficiencies HIV/AIDS

HIV INFECTION: An Overview

HIV Infection and Epidemiology: Can There Be a Cure? Dr. Nedwidek

The Struggle with Infectious Disease. Lecture 6

Virology Introduction. Definitions. Introduction. Structure of virus. Virus transmission. Classification of virus. DNA Virus. RNA Virus. Treatment.

There are 2 major lines of defense: Non-specific (Innate Immunity) and. Specific. (Adaptive Immunity) Photo of macrophage cell

GOVX-B11: A Clade B HIV Vaccine for the Developed World

CELL BIOLOGY - CLUTCH CH THE IMMUNE SYSTEM.

An Analysis of Genital Tract Derived HIV from Heterosexual Transmission Pairs. Debrah Boeras Emory University October 14, 2008

Chapter 13 Lymphatic and Immune Systems

October 26, Lecture Readings. Vesicular Trafficking, Secretory Pathway, HIV Assembly and Exit from Cell

Decay characteristics of HIV-1- infected compartments during combination therapy

Building complexity Unit 04 Population Dynamics

19/06/2013. Viruses are not organisms (do not belong to any kingdom). Viruses are not made of cells, have no cytoplasm, and no membranes.

I. Bacteria II. Viruses including HIV. Domain Bacteria Characteristics. 5. Cell wall present in many species. 6. Reproduction by binary fission

Understanding HIV. Transmitted/Founder Viruses. Brandon Keele SAIC-Frederick National Cancer Institute

7.014 Problem Set 7 Solutions

Chapter 13 Viruses, Viroids, and Prions. Biology 1009 Microbiology Johnson-Summer 2003

HIV and drug resistance Simon Collins UK-CAB 1 May 2009

, virus identified as the causative agent and ELISA test produced which showed the extent of the epidemic

Emerging Viruses. Part IIb Follow Up from Part I Vaccines and Inhibitors

Session 1 Basic HIV Facts. Patient Navigation Intervention

LESSON 1.4 WORKBOOK. Viral sizes and structures. Workbook Lesson 1.4

Lecture 2 Evolution in action: the HIV virus

Evaluation and Management of Virologic Failure

RAISON D ETRE OF THE IMMUNE SYSTEM:

Section 6. Junaid Malek, M.D.

Biotechnology-Based Vaccines. Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel:

ACQUIRED IMMUNODEFICIENCY SYNDROME AND ITS OCULAR COMPLICATIONS

Chronic HIV-1 Infection Frequently Fails to Protect against Superinfection

Clinical utility of NGS for the detection of HIV and HCV resistance

Current Strategies in HIV-1 Vaccine Development Using Replication-Defective Adenovirus as a Case Study

Antiviral Chemotherapy

Chapter 19: Viruses. 1. Viral Structure & Reproduction. What exactly is a Virus? 11/7/ Viral Structure & Reproduction. 2.

2.1 VIRUSES. 2.1 Learning Goals

VIRUSES. Biology Applications Control. David R. Harper. Garland Science Taylor & Francis Group NEW YORK AND LONDON

Julianne Edwards. Retroviruses. Spring 2010

Transcription:

The Swarm: Causes and consequences of HIV quasispecies diversity Julian Wolfson Dept. of Biostatistics - Biology Project August 14, 2008

Mutation, mutation, mutation Success of HIV largely due to its ability to escape control of immune system/drug treatment via rapid mutation 10 9-10 10 viral particles produced each day, 3 mutations per particle enormous diversity possible

Mutation, mutation, mutation Success of HIV largely due to its ability to escape control of immune system/drug treatment via rapid mutation 10 9-10 10 viral particles produced each day, 3 mutations per particle enormous diversity possible Vast majority of mutations cripple virus, but small number confer evolutionary advantage

Mutation, mutation, mutation Success of HIV largely due to its ability to escape control of immune system/drug treatment via rapid mutation 10 9-10 10 viral particles produced each day, 3 mutations per particle enormous diversity possible Vast majority of mutations cripple virus, but small number confer evolutionary advantage The Swarm Within an infected person, HIV exists as a genetically diverse population of competing quasispecies

Quasispecies Questions: How do we characterize HIV sequence diversity in an infected patient? What is the balance point between ability to resist selective pressure and overall viral function? How is quasispecies diversity maintained in the face of this pressure? What are the consequences of viral diversity?

1 HIV Infection, briefly 2 Sequencing Techniques 3 Viral Fitness 4 Inducing Diversity 5 Maintaining Diversity 6 Impact of Diversity 7 Summary

1 HIV Infection, briefly 2 Sequencing Techniques 3 Viral Fitness 4 Inducing Diversity 5 Maintaining Diversity 6 Impact of Diversity 7 Summary

Natural Course of Infection

Stage 1: Acute/Early Infection Virus enters body, infects a number of possible target cells (eg. Langerhans, dendritic, macrophage, CD4)

Stage 1: Acute/Early Infection Virus enters body, infects a number of possible target cells (eg. Langerhans, dendritic, macrophage, CD4) Very high viral loads, CD4+ (T helper cell) levels drop dramatically Flu-like symptoms

Stage 1: Acute/Early Infection Virus enters body, infects a number of possible target cells (eg. Langerhans, dendritic, macrophage, CD4) Very high viral loads, CD4+ (T helper cell) levels drop dramatically Flu-like symptoms Vigorous CD8+ (T killer cell) response, killing many HIV-infected cells. CD4+ levels rebound, but do not reach original levels.

Stage 2: Immune Control Virus remains active in lymphoid tissue, mutations accumulate Reservoirs persist in other parts of the body (i.e. gut) Gradual decrease in CD4+ levels over a two-week to 20-year period

Stage 3: Immune Failure CD4+ count drops to level where cell-mediated immunity is no longer effective Viral load rises sharply, progression to AIDS

1 HIV Infection, briefly 2 Sequencing Techniques 3 Viral Fitness 4 Inducing Diversity 5 Maintaining Diversity 6 Impact of Diversity 7 Summary

Basic Sequencing

Basic Sequencing Issues Viral sequences may differ across tissues

Basic Sequencing Issues Viral sequences may differ across tissues May miss rare sequences, misrepresent population diversity If small number of genomes in original sample (ie. very low viral load), may amplify same template sequence more than once a a Liu 1996

Limiting Dilution Isolate individual sequences via dilution, then amplify to get enough copies for sequencing Limited by number of individual genomes which can be sequenced in reasonable amount of time

Pyrosequencing Yields large number of short (200-400 bp) reads Can be automated fast Computational techniques for haplotype/frequency estimation

Pyrosequencing Yields large number of short (200-400 bp) reads Can be automated fast Computational techniques for haplotype/frequency estimation Limitations Works best when known template sequence available Subject to quality of algorithms applied

1 HIV Infection, briefly 2 Sequencing Techniques 3 Viral Fitness 4 Inducing Diversity 5 Maintaining Diversity 6 Impact of Diversity 7 Summary

Viral fitness Genetic variability causes individual viruses to have different abilities to: 1 Infect cells 2 Replicate within cells 3 Cause clinical disease

Viral fitness Genetic variability causes individual viruses to have different abilities to: 1 Infect cells 2 Replicate within cells 3 Cause clinical disease For our purposes, Viral fitness = Replication Capacity / Persistence in vivo

Viral fitness Genetic variability causes individual viruses to have different abilities to: 1 Infect cells 2 Replicate within cells 3 Cause clinical disease For our purposes, Viral fitness = Replication Capacity / Persistence in vivo May differ from fitness in vitro

In vitro vs. in vivo Figure: HIV quasispecies fitness maps for two individuals [Fernandez 2007]

Replication capacity / persistence Characteristics which affect a virus ability to survive and replicate in vivo over a long period of time include: Epitope sequences Tissue tropism Ability of viral proteins (eg. protease, reverse transcriptase) to function efficiently in presence of Abs/ART

1 HIV Infection, briefly 2 Sequencing Techniques 3 Viral Fitness 4 Inducing Diversity 5 Maintaining Diversity 6 Impact of Diversity 7 Summary

Initial Infection Early quasispecies diversity limited by transmission bottleneck 1 (unrelated to replication capacity?) Quasispecies which become established are not necessarily fittest/most virulent of infecting population 1 Karlsson1998 2 Bergstrom 1999

Initial Infection Early quasispecies diversity limited by transmission bottleneck 1 (unrelated to replication capacity?) Quasispecies which become established are not necessarily fittest/most virulent of infecting population May decrease viral fitness over sequential transmissions 2 1 Karlsson1998 2 Bergstrom 1999

Selection Forces After infection is established, three major selection forces act on HIV quasispecies: 1 The host s natural immune response, mediated by antibodies and T cells 2 Competition between quasispecies for limited resources 3 Drug therapy, if applicable

Natural Immune Response - Antibodies Antibodies attach to outer surface of circulating virus particles, neutralizing them In HIV, main target is viral envelope (encoded by env gene) Constant interplay 3 between Quasispecies mutation to avoid detection by antibodies Production of antibodies which recognize currently circulating quasispecies 3 Richman 2003

Natural Immune Response - T cells T cells recognize epitope, small piece of viral protein presented on surface of infected cell Recognition of viral epitope triggers T-cell-mediated destruction of cell Viruses with unrecognizable epitopes can remain undetected in a cell Epitope presentation/recognition by CD8+ varies by individual s HLA type a a Lichterfeld 2005

Viral Competition Fitness cost associated with escape mutations (CTL or HAART) can be high Viruses carrying these mutations may be out-competed by more efficient (eg. wild-type) virus in absence of selective pressure 4 Potential loss of resistance mutations forms the basis of drug holiday and intermittent therapy regimens 4 Leslie 2004, Friedrich 2004

Drug Therapy and Quasispecies Quasispecies theory 5 shows why single-drug regimens (eg. AZT) failed: Initial therapy causes reduction in viral load, increases supply of uninfected cells 5 Frost 1994 6 Petravic 2008

Drug Therapy and Quasispecies Quasispecies theory 5 shows why single-drug regimens (eg. AZT) failed: Initial therapy causes reduction in viral load, increases supply of uninfected cells Mutant strains resistant to (single) drug arise 5 Frost 1994 6 Petravic 2008

Drug Therapy and Quasispecies Quasispecies theory 5 shows why single-drug regimens (eg. AZT) failed: Initial therapy causes reduction in viral load, increases supply of uninfected cells Mutant strains resistant to (single) drug arise Mutants, nearly as fit as original strains, benefit from large number of uninfected cells to maintain infection 6 5 Frost 1994 6 Petravic 2008

Drug Therapy and Quasispecies Quasispecies theory 5 shows why single-drug regimens (eg. AZT) failed: Idea Initial therapy causes reduction in viral load, increases supply of uninfected cells Mutant strains resistant to (single) drug arise Mutants, nearly as fit as original strains, benefit from large number of uninfected cells to maintain infection 6 Raise barriers to escape so that viruses which carry necessary mutations are likely to have low replication capacity 5 Frost 1994 6 Petravic 2008

HAART Highly Active Anti-Retroviral Therapy now standard treatment in developed countries Involves a combination of three or more drugs from the following categories: 1 Nucleoside Reverse Transcriptase Inhibitors (NRTI) 2 Non-Nucleoside RTIs (NNRTI) 3 Protease Inhibitors (PI) 4 Integrase Inhibitors 5 Entry Inhibitors 6 Maturation Inhibitors Difficult for HIV to mutate to evade 3 drugs simultaneously without severe loss of replicative capacity

Breaking bottlenecks HAART exerts extreme selective pressure on HIV, yet: Drug holiday and intermittent therapy regimes have had limited success in practice Recent studies 7 have found quasispecies resistant to multiple drugs 7 Quan 2008

Breaking bottlenecks HAART exerts extreme selective pressure on HIV, yet: Drug holiday and intermittent therapy regimes have had limited success in practice Recent studies 7 have found quasispecies resistant to multiple drugs An Implacable Foe? Intense selective pressure tends to create evolutionary bottlenecks which decrease quasispecies diversity... 7 Quan 2008

Breaking bottlenecks HAART exerts extreme selective pressure on HIV, yet: Drug holiday and intermittent therapy regimes have had limited success in practice Recent studies 7 have found quasispecies resistant to multiple drugs An Implacable Foe? Intense selective pressure tends to create evolutionary bottlenecks which decrease quasispecies diversity... but viral population remains heterogeneous 7 Quan 2008

Breaking bottlenecks HAART exerts extreme selective pressure on HIV, yet: Drug holiday and intermittent therapy regimes have had limited success in practice Recent studies 7 have found quasispecies resistant to multiple drugs An Implacable Foe? Intense selective pressure tends to create evolutionary bottlenecks which decrease quasispecies diversity... but viral population remains heterogeneous How is quasispecies diversity maintained? 7 Quan 2008

1 HIV Infection, briefly 2 Sequencing Techniques 3 Viral Fitness 4 Inducing Diversity 5 Maintaining Diversity 6 Impact of Diversity 7 Summary

Recombination A major force for introducing new (possibly resistant) quasispecies into viral population 8 Charpentier 2006

Recombination A major force for introducing new (possibly resistant) quasispecies into viral population Possibly also a mechanism for avoiding evolutionary bottlenecks 8 : Fitness peak jumping Limit size of regions which are homogeneous across quasispecies 8 Charpentier 2006

Compartmentalization Distinct quasispecies populations may become established in different parts of the body, eg. gut, blood, CSF 9, breast milk 10, genital tract 11, and CD4 cells 12 9 Harrington 2007, Abbate 2005, Caragounis 2008 10 Becquart 2002 11 Diem 2008 12 Fulcher 2004 13 van Marle 2007 14 Chen 2006

Compartmentalization Distinct quasispecies populations may become established in different parts of the body, eg. gut, blood, CSF 9, breast milk 10, genital tract 11, and CD4 cells 12 Further evidence of compartmentalization within certain organs (gut 13, brain 14 ) 9 Harrington 2007, Abbate 2005, Caragounis 2008 10 Becquart 2002 11 Diem 2008 12 Fulcher 2004 13 van Marle 2007 14 Chen 2006

Compartmentalization Distinct quasispecies populations may become established in different parts of the body, eg. gut, blood, CSF 9, breast milk 10, genital tract 11, and CD4 cells 12 Further evidence of compartmentalization within certain organs (gut 13, brain 14 ) May arise as response to different biological conditions within compartments 9 Harrington 2007, Abbate 2005, Caragounis 2008 10 Becquart 2002 11 Diem 2008 12 Fulcher 2004 13 van Marle 2007 14 Chen 2006

Compartmentalization Distinct quasispecies populations may become established in different parts of the body, eg. gut, blood, CSF 9, breast milk 10, genital tract 11, and CD4 cells 12 Further evidence of compartmentalization within certain organs (gut 13, brain 14 ) May arise as response to different biological conditions within compartments Some suggestion that reservoirs may exchange genetic information (Diem, Harrington) 9 Harrington 2007, Abbate 2005, Caragounis 2008 10 Becquart 2002 11 Diem 2008 12 Fulcher 2004 13 van Marle 2007 14 Chen 2006

Archiving Resting T cells can harbour replication-competent virus over a long period of time 15 Ruff 2002

Archiving Resting T cells can harbour replication-competent virus over a long period of time Allows for archiving of quasispecies over entire infection history 15 15 Ruff 2002

Archiving Resting T cells can harbour replication-competent virus over a long period of time Allows for archiving of quasispecies over entire infection history 15 Macrophages, other cell types may also serve similar archiving role 15 Ruff 2002

Archiving Resting T cells can harbour replication-competent virus over a long period of time Allows for archiving of quasispecies over entire infection history 15 Macrophages, other cell types may also serve similar archiving role Rewind ability allows HIV to adapt quickly to change in biological conditions 15 Ruff 2002

1 HIV Infection, briefly 2 Sequencing Techniques 3 Viral Fitness 4 Inducing Diversity 5 Maintaining Diversity 6 Impact of Diversity 7 Summary

Impact of Diversity Quasispecies diversity plays an important role in ensuring HIV s survival by 1 Ensuring the stability of the viral population 2 Improving adaptability to different biological conditions through cooperative interactions 3 Helping to thwart drug therapy regimes

Population Stability: Survival of the flattest? Theory based on ideas of Eigen and Schuster 16, verified in silico 17 and in vivo 18 Basic idea: Collection of quasispecies with higher average fitness will outcompete one with lower average fitness, even if latter contains individuals with very high fitness 16 Schuster 1988, Eigen 1996 17 Wilke 2001 18 Elena 2008

Fitness 0.0 0.2 0.4 0.6 0.8 3 2 1 0 1 2 3 Genetic distance

Cooperative interactions Quasispecies theory predicts that viral populations, not individual variants, are the target of evolutionary selection. Neat experiment [Vignuzzi 2006] Compare growth of wild-type (WT) poliovirus to one with high-fidelity (HF) polymerase in vitro and in vivo

Cooperative interactions, cont d. Results - in vitro

Cooperative interactions, cont d. Results - in vitro WT outcompetes HF under adverse conditions Limiting quasispecies diversity lowers replication capacity Results - in vivo

Cooperative interactions, cont d. Results - in vitro WT outcompetes HF under adverse conditions Limiting quasispecies diversity lowers replication capacity Results - in vivo HF highly attenuated as compared to WT, unable to survive in neurological tissue

Cooperative interactions, cont d. Results - in vitro WT outcompetes HF under adverse conditions Limiting quasispecies diversity lowers replication capacity Results - in vivo HF highly attenuated as compared to WT, unable to survive in neurological tissue Artificially increasing quasispecies diversity in HF population restored pathogenicity/neurotropism to WT levels

Cooperative interactions, cont d. Results - in vitro WT outcompetes HF under adverse conditions Limiting quasispecies diversity lowers replication capacity Results - in vivo HF highly attenuated as compared to WT, unable to survive in neurological tissue Artificially increasing quasispecies diversity in HF population restored pathogenicity/neurotropism to WT levels Artifically diversified HF and WT brain isolates genetically indistinguishable, but only WT isolate was neurotropic when injected into a new host!

Cooperative interactions, cont d. Results - in vitro WT outcompetes HF under adverse conditions Limiting quasispecies diversity lowers replication capacity Results - in vivo HF highly attenuated as compared to WT, unable to survive in neurological tissue Artificially increasing quasispecies diversity in HF population restored pathogenicity/neurotropism to WT levels Artifically diversified HF and WT brain isolates genetically indistinguishable, but only WT isolate was neurotropic when injected into a new host! Conclusion Sequence diversity itself, not particular set of mutations, determines pathogenesis

Drug resistance Compartmentalization can limit effectiveness of drug treatment in places where ARs may not penetrate (eg. brain)

Drug resistance Compartmentalization can limit effectiveness of drug treatment in places where ARs may not penetrate (eg. brain) Recombination restricts evolutionary bottleneck effect to very specific genomic regions, maintains diversity at adjacent regions

Drug resistance Compartmentalization can limit effectiveness of drug treatment in places where ARs may not penetrate (eg. brain) Recombination restricts evolutionary bottleneck effect to very specific genomic regions, maintains diversity at adjacent regions Archiving maintains a catalogue of viruses resistant to previous treatments, making previously-tried drugs ineffective

1 HIV Infection, briefly 2 Sequencing Techniques 3 Viral Fitness 4 Inducing Diversity 5 Maintaining Diversity 6 Impact of Diversity 7 Summary

Summary HIV exists as a complex and dynamic population within infected individuals, shaped by selective pressure due to immune response, competition, and drug treatment

Summary HIV exists as a complex and dynamic population within infected individuals, shaped by selective pressure due to immune response, competition, and drug treatment Quasispecies diversity is crucial to HIV s survival in face of these selection forces

Summary HIV exists as a complex and dynamic population within infected individuals, shaped by selective pressure due to immune response, competition, and drug treatment Quasispecies diversity is crucial to HIV s survival in face of these selection forces Future vaccine and therapy approaches will need to account for and/or exploit HIV intrahost population dynamics

Acknowledgements Prof. Peter Gilbert Prof. Julie Overbaugh Anne Piantadosi Thanks! Questions?